Home › Prostate Cancer › Wisconsin › Manitowoc
Prostate Cancer clinical trials in Manitowoc, WI
3 studies for Prostate Cancer are looking for participants at sites in and around Manitowoc (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers · 6 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers · 6 mi away
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers · 6 mi away
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Manitowoc
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Breast Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)4 studies
- Colorectal Cancer4 studies
- Cancer (all types)3 studies
- Ovarian Cancer3 studies
- Pancreatic Cancer3 studies
- Colon Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.